Microvast's new all-solid-state battery technology eliminates liquid electrolytes for improved safety and higher energy ...
Celltrion’s denosumab biosimilar demonstrated equivalent efficacy, safety, and immunogenicity compared with the originator in a phase 3 trial involving postmenopausal women with osteoporosis, paving ...